RegisterLogin

C8 Dihydroceramide

CAT: 804-HY-119312Size: 1 mgDry Ice: NoHazardous: No
1 mgSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
C8 Dihydroceramide is a negative control of C8 Ceramide. C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. C8-Ceramide has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections. C8-Ceramide induces slight activation of protein kinase (PKC) in vitro[1][2][3][4].
CAS Number
[145774-33-0]
UNSPSC
12352211
Target
PKC
Type
Reference compound
Related Pathways
Epigenetics; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/c8-dihydroceramide.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H]([C@@H](CCCCCCCCCCCCCCC)O)CO)CCCCCCC
Molecular Formula
C26H53NO3
Molecular Weight
427.70
References & Citations
[1]Rebeca López-Marure , et al. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun. 2002 May 10;293 (3) :1028-36.|[2]Yuli C. Chang, et al. Exogenous C8-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells. Int J Mol Sci. 2018 Oct; 19 (10) : 3010.|[3]H W Huang, et al. Ceramides modulate protein kinase C activity and perturb the structure of Phosphatidylcholine/Phosphatidylserine bilayers. Biophys J. 1999 Sep; 77 (3) : 1489-1497.|[4]Lan Weiss, et al. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Hum Mol Genet. 2021 Jan 7; ddaa248.|[5]Rebeca López-Marure, et al. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun. 2002 May 10;293 (3) :1028-36.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W590670-01C20-Dihydroceramide
HY-W590669-01C16-Dihydroceramide
HY-W590672C22-Dihydroceramide
HY-141580-01C18 Dihydroceramide
HY-W590664-01C2 Dihydroceramide
HY-W588183-01C14-Dihydroceramide
HY-W590665-01C4 Dihydroceramide
HY-141580SC18 Dihydroceramide-d3
HY-141580S1C18 Dihydroceramide-d3-1
HY-D1576C6 NBD L-threo-dihydroceramide

Alternative Products

CatalogName
MBS808102-01Dihydroceramide
SIH-398-25MGDihydroceramide
SIH-398-5MGDihydroceramide
267803-01C2 dihydroceramide
TYD-02066-01C22-Dihydroceramide
MBS565546-01C6 Dihydroceramide
TRC-C262830-5MGC14 Dihydroceramide
TRC-C263130-50MGC20 Dihydroceramide
TRC-C263145-10MGC22 Dihydroceramide
sc-205611AC8 Dihydroceramide

Popular Products